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Purpose:  Crohn’s  disease  is  a  type  of  inﬂammatory  bowel  disease  affecting  estimated  4 million  people
worldwide.  Therapy  stratiﬁcation  of  Crohn’s  disease  (CD)  is  mainly  based  on  the  inﬂammatory  activity
being  assessed  by  endoscopic  biopsy  and  clinical  criteria.  Cross-sectional  imaging  allows  for  the  assess-
ment  of structural  characteristics  of  the entire  gastrointestinal  tract  including  small  bowel  loops  and  may
provide potential  non-invasive  image-based  biomarkers  for the  inﬂammatory  activity  of CD.  The  aim of
this study was  to  explore  the predictive  value  of  Computed  Tomography-based  morphologic  patterns  for
inﬂammatory  activity  in  CD.
Material  and  methods:  42  patients  diagnosed  with  CD  were  included  in a  retrospective  study  (13  male,
29  female,  median  age  32 years).  Abdominal  CT imaging  was  carried  out  on  symptomatic  patients  at  a
single  institution  0–10  days  prior  to  endoscopic  biopsy  or surgery  using  a protocol  optimized  for  the
characterization  of  structural  bowel  alterations.  Image  data  were  initially  reviewed  independently  by
three radiologists  and  discrepancies  were  settled  in consensus  with  a focus  on mesenteric  fat  stranding
and  combing,  mesenteric  adenopathy,  mesenteric  abscess,  intraperitoneal  free  ﬂuid,  ﬁstula,  skip  lesions,
highest  wall  thickness  and  the  localization  of the affected  bowel.  The  extent  of  inﬂammatory  activity  in
the bowel  wall  was  determined  subsequently  by  histological  analysis.
Results:  All  intestinal  and  extraintestinal  CT  ﬁndings  except  the  mesenteric  comb  sign  showed  a  tendency
towards  higher  extent  or prevalence  in patients  with  high  histological  inﬂammatory  activity  score,  espe-
cially median  bowel  wall thickness  (6.0 mm  vs. 3.5  mm),  mesenteric  abscesses  (32%  vs.  0%) and  mesenteric
adenopathy  (94%  vs. 45%).  Spearman  rank  order  correlation  coefﬁcient  indicated  a  signiﬁcant  correlation
of  bowel  wall  thickness  (r = 0.40,  p < 0.05),  mesenteric  adenopathy  (r = 0.54,  p <  0.05),  mesenteric  abscess
(r  = 0.33,  p  <  0.05)  and  mesenteric  fat  stranding  (r =  0.33,  p <  0.05)  with  the  histological  inﬂammatory
activity  score.
Conclusion:  CT-based  biomarkers  including  wall thickness,  mesenteric  fat  stranding,  mesenteric  lym-
phadenopathy  and mesenteric  abscess  positively  correlated  with  the  histological  inﬂammatory  activity
score  and therefore  provided  additional  information  for therapy  stratiﬁcation  in  symptomatic  patients
with  CD,  particularly  as most  of  these  biomarkers  are  hidden  from  endoscopy.
© 2016  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND
license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).∗ Corresponding author at: Radiologie Klinik Hirslanden, Klinik Hirslanden, Witellikers
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Table  1
Summary of patient characteristics.
Histological inﬂammatory activity score
0–2 3 Overall
n 11 31 42
Male (n)/Female (n) 2/9 11/20 13/29
D
1
t
t
t
b
D
r
M
a
a
u
e
i
b
i
s
a
p
a
i
w
m
p
i
t
c
m
t
m
2
2
i
p
a
i
c
d
m
C
o
s
h
i
i
m
a
d
wAge (y) 26 (20–36) 38 (23–65) 32 (20–65)
ata are median and range in brackets.
. Introduction
Crohn’s Disease (CD) is regarded as an unpredictable, relapsing,
ransmural inﬂammatory disease potentially affecting any part of
he gastrointestinal tract (GI) [1]. It usually involves the large intes-
ine and the distal small bowel causing inﬂammation, ulcerations,
leeding and ultimately ﬁbrosis and scarring of the GI tract wall [2].
Proper diagnosis of CD is challenging and requires multiple tests.
iagnosis is based on medical history, physical examination, labo-
atory tests, endoscopy including biopsy and imaging studies. The
ontreal classiﬁcation [3] with age at diagnosis, location, behavior
nd the CD Activity Index (CDAI) [4] are widely used for disease
ssessment and therapy stratiﬁcation. However, these scores are
nreliable in differentiating remission and active CD [5]. Currently,
ndoscopy and biopsy are the gold standard for assessing the
nﬂammatory activity of CD. Nevertheless, diagnosis in the small
owel disease is difﬁcult to achieve, because common endoscopy
s limited to the colon and distal small bowel. Furthermore, endo-
copic examination including biopsy is not always immediately
vailable and can be stressful for the patient. In contrast, Com-
uted Tomography (CT) imaging is widely available and provides
 non-invasive method for the evaluation of the entire GI tract
ncluding extraintestinal manifestations and complications of CD,
hich are not visible by endoscopy. CT and MRI  are the imaging
odalities of choice to depict the localization and CD severity and
rovide information on disease activity. Imaging of the morpholog-
cal characteristics of CD include assessment of mucosal alterations,
ransmural involvement and extraintestinal manifestations. In this
ontext, CT may  provide image-based biomarkers for the inﬂam-
atory activity of CD, which could further contribute to effective
herapy stratiﬁcation. Here, we explore the potential value of CT
orphologic pattern as predictor of inﬂammatory activity in CD.
. Material and methods
.1. Patient characteristics
We  researched retrospectively the hospital database at a single
nstitution for a period of 5 years. Inclusion criteria were a CT scan
erformed 0–10 days prior to endoscopic biopsy or surgery and
 histopathologically proven diagnosis of CD. Patients with other
maging modalities or with a CT scan but without histopathological
orrelation were excluded from the study. We  included 42 patients
iagnosed with CD in our retrospective study (13 male, 29 female,
edian age 32 years), who underwent abdominal Multidetector
omputed Tomography (MDCT) imaging 0–10 days prior to biopsy
r surgery. MDCT datasets were acquired at a single institution.
The study entailed patients with acute symptoms and a broad
pectrum of inﬂammatory activity, which was determined by
istological analysis of bowel wall tissue specimens. Absence of
nﬂammatory activity (score = 0) was found in 2/42 patients, mild
nﬂammatory activity (score = 1) in 5/42 patients, moderate inﬂam-
atory activity (score = 2) in 4/42 patients and high inﬂammatory
ctivity (score = 3) in 31/42 patients (Table 1). Patients were pre-
ominantly female. Median age was 32 years (Table 1). The study
as approved by the local Ethics Committee. The work was carriedFig. 1. 33 year old man, axial contrast-enhanced MDCT image of small bowel wall
thickening (big arrow) and comb sign (small arrow) involving the distal ileum.
out in accordance with The Code of Ethics of the World Medi-
cal Association (Declaration of Helsinki). Informed consent was
waived.
2.2. Histological analysis
The histological evaluation of the inﬂammatory activity in the
bowel wall served as a reference standard. After macroscopic
examination, endoscopic and surgical bowel specimens underwent
ﬁxation with formalin and standard hematoxylin-eosin safran stain
and microscopic analysis. The extent of inﬂammatory activity was
reported by a pathologist with experience in inﬂammatory bowel
disease who  was  blinded for clinical, biological and radiological
data. The standardized evaluation process was based on a semi-
quantitative visual 4-point scale of 0 = absence of inﬂammation,
1 = mild inﬂammation (neutrophil inﬁltrate limited to the mucosa),
2 = moderate inﬂammation (neutrophil inﬁltrate limited to mucosa
and submucosa), and 3 = high inﬂammation (transmural neutrophil
inﬁltrate affecting the muscularis propria or ﬁstula/abscess of the
subserosa) (Fig. 3).
2.3. Computed tomography imaging
CT imaging was  performed using a 16 row MDCT unit (GE 16
Light Speed CT scanner, General Electric, Milwaukee, WI,  USA) using
an imaging protocol dedicated to the assessment of structural alter-
ations of the GI tract. Distension of small bowel loops was  obtained
by administration of approximately 1.0 L oral contrast medium
(3% Gastrograﬁn solution, meglumine diatrizoate, Bristol-Myers
Squibb) over 60 min. Intravenous contrast of 100 mL iopromide
(Ultravist 300, 300 mg  iodine/mL; Bayer HealthCare Pharmaceu-
ticals Inc, Wayne, NJ) was  injected at a rate of 3.0 mL/sec and
bolus-tracking with a region of interest in the descending aorta
at the level of the ﬁrst lumbar vertebra was applied to gener-
ate enteric phase CT data. Image acquisition started at 35 s after
the trigger (trigger threshold level 100HU [Hounsﬁeld Unit]) dur-
ing breathhold at a mean inspiratory level. Axial and coronal CT
images (slice thickness 5.0 mm,  reconstruction interval 3.0 mm)
were reconstructed and transferred to a picture archiving and com-
munication (PACS) system for image interpretation.
2.4. MDCT image evaluation
Image data were independently reviewed by three experienced
radiologists who were blinded to clinical or histopathological data.
Discrepancies were settled in consensus. The presence or absence of
potential CT ﬁndings related to CD including mesenteric fat strand-
ing, comb sign (Fig. 1), mesenteric adenopathy, mesenteric abscess,
76 N. Paquet et al. / European Journal of Radiology Open 3 (2016) 74–78
Fig. 2. 40 year old women, axial contrast-enhanced MDCT image of bowel wall
thickening and mucosal enhancement involving long segment of distal ileum (big
arrow).
Fig. 3. 40 year old women, typical active inﬂammatory reaction of the gastrointesti-
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Table 3
Correlation of CT ﬁndings with histological inﬂammatory activity score.
Inﬂammatory activity vs. Cases n Rho p
Wall thickness 42 0.40 <0.05
Mesenteric fat stranding 42 0.33 <0.05
Mesenteric adenopathy 42 0.54 <0.05
Mesenteric abscess 42 0.33 <0.05
Spearman rank order correlation coefﬁcient Rho calculated for the extent of bowel
between the prevalence of mesenteric adenopathy and histolog-
ical inﬂammatory activity score (r = 0.54, p < 0.05) (Table 3). There
T
P
T
ﬁ
t
aal  mucosa characterized by neutrophilic invasion of mucosal glands.
ree intraperitoneal ﬂuid, ﬁstula, skip lesions, wall thickness (Fig. 2)
nd localization of the affected bowel segment were reported. The
aximum wall thickness of inﬂamed bowel was quantiﬁed by
anual measurement on axial or coronal image reconstructions,
epending on the most appropriate image orientation. Image qual-
ty was evaluated visually with a semi-quantitative 5-point scale
0 = poor, not diagnostic, 1 = reduced but diagnostic, 2 = moderate,
 = good, 4 = excellent) .
able 2
revalence or extent of CT ﬁndings in relation to histological inﬂammatory activity.
CT-based biomarkers prevalence (%)/extent (mm) Histologi
0–2 
Wall thickness 3.5 mm (Q
Mesenteric fat stranding 73% 
Mesenteric comb sign 64% 
Mesenteric lymphadenopathy 45% 
Mesenteric abscess 0% 
Intraperitoneal free ﬂuid 18% 
Fistula 27% 
Skip  lesions 45% 
he prevalence of CT ﬁndings in the abdominal digestive tract including mesenteric fat 
stula  and skip lesions as well as the extent of bowel wall thickening tended to be higher
o  patients with low to moderate inﬂammatory activity (score = 0–2). The prevalence of 
ctivity.wall thickening, the presence of mesenteric fat stranding, adenopathy, and abscesses
with histological inﬂammatory activity score in CD.
2.5. Statistical analysis
Basic descriptive data were expressed as medians with
interquartile range (Q1–Q3). Calculations were performed with
SPSS 22 (IBM, Armonk, New York, USA). Spearman’s rank corre-
lation coefﬁcient was calculated for potential CT-biomarkers and
histological inﬂammatory activity score. By convention, r between
0.0–0.2 was  regarded as negligible, 0.2–0.4 as weak, 0.4–0.7 moder-
ate, 0.7–0.9 strong, and 0.9–1.0 very strong correlation [6]. Multiple
testing was  compensated for by the Bonferroni-Holm method [7].
3. Results
All patient datasets showed diagnostic image quality. Speciﬁ-
cally, image quality was estimated to be excellent in the majority
(34/42) of patients. Good image quality was found in 6/42 and mod-
erate image quality in 2/42 patients, in such cases it was mainly due
to mild respiratory motion artifacts.
Considering the relatively small number of individuals with low
to moderate inﬂammatory activity score, we formed two  patient
groups (score = 0–2 vs. score = 3) for the tabular display of descrip-
tive data (Table 2). All intestinal and extraintestinal MDCT ﬁndings
except the mesenteric comb sign showed a tendency towards
higher prevalence or extent in patients with high histological
inﬂammatory activity score (Table 2). Notably, the extent of bowel
wall thickness (6.0 mm vs. 3.5 mm),  and the prevalence of mesen-
teric abscesses (32% vs. 0%) and mesenteric adenopathy (94% vs.
45%) tended to be higher in patients with a high inﬂammatory
activity score (Table 2).
Including all degrees of severity of the histologically assessed
inﬂammatory activity, Spearman rank order correlation coefﬁcient
indicated a moderate correlation between the extent of bowel wall
thickness and histological inﬂammatory activity score (r = 0.40,
p < 0.05) (Table 3). Moreover, there was a moderate correlationwas also a weak correlation between mesenteric abscesses and
mesenteric fat stranding with histological inﬂammatory activity
cal inﬂammatory activity score
3
1 = 1.3; Q3= 4.0) 6.0 mm (Q1= 5.0; Q3= 7.0)
94%
48%
94%
32%
39%
38%
60%
stranding, mesenteric adenopathy, mesenteric abscess, intra-peritoneal free ﬂuid,
 in patients with high histological inﬂammatory activity score (score = 3) compared
the mesenteric comb sign tended to be lower in patients with high inﬂammatory
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core (each r = 0.33, p < 0.05) (Table 3). Other MDCT ﬁndings related
o CD did not show a signiﬁcant correlation with the histological
nﬂammatory activity score. Moreover, there was no statistically
igniﬁcant correlation between the localization of affected bowel
egments and the inﬂammatory activity score. Speciﬁcally, lesions
ith low or moderate (score = 0–2) and high (score = 3) inﬂamma-
ory activity scores were located predominantly in the ileocolic
egion (21% vs. 38%) and in the ileum (3% vs. 28%). Few lesions
ith low/moderate and high inﬂammatory activity were found
n the colon (3% vs. 5%). Other bowel segments such as the
ppendix were affected in 3% of cases with high inﬂammatory
ctivity.
. Discussion
In the present study, we aimed to explore the potential value
f various intestinal and extraintestinal MDCT-based morpho-
ogic patterns to evaluate the extent of inﬂammatory activity in
D. Inﬂammatory activity determined by histological analysis was
ighly prevalent (95%) in this patient cohort. Imaging patterns of
nﬂammatory bowel alterations were detected by MDCT in 41/42
ubjects with active CD, conﬁrming the ability of CT to detect
nﬂammation in patients with inﬂammatory bowel disease [8]. This
nding is supported by Chiorean et al. who found a high sensitivity
f CT enteroclysis in the diagnosis of CD with CT and demon-
trated the ability of CT to differentiate between inﬂammatory and
brostenotic lesions [9].
The main localization of inﬂammation was found in the ileum
nd ileocolic region in 23% of lesions with low to moderate inﬂam-
atory activity and in 67% of lesions with high activity. This allows
DCT to play to its strengths, since small bowel loops are difﬁ-
ult to reach with endoscopy, accompanied by increased risk for
leeding, perforation and capsule retention if capsule endoscopy
s performed [10]. Boudiaf et al. demonstrated the ability of CT
o depict small bowel abnormalities with a sensitivity of 100%, a
peciﬁcity of 95%, a positive predictive value of 94% and a negative
redictive value of 100% [11].
We  found a signiﬁcant correlation of MDCT-based patterns of
owel inﬂammation and the histological inﬂammatory activity
core. In this context, four different patterns appeared to be valu-
ble predictors of inﬂammatory activity: mesenteric adenopathy
highest correlation), bowel wall thickness (moderate correlation)
nd mesenteric abscess/fat stranding (weak correlation) with the
istological inﬂammatory activity score. Consequently, mesenteric
denopathy showed high prevalence in patients with high inﬂam-
atory activity (94%) compared to patients with no or low activity
45%). Mesenteric fat stranding showed high prevalence both in
atients with high (94%) as well as moderate inﬂammatory activity
73%).
Abscesses were infrequent and found in subjects with high
nﬂammatory activity. Bowel wall thickness was  almost twice as
igh in patients with high inﬂammatory activity (6.0 vs. 3.5 mm).
esults of Zissin et al. also showed CT ﬁndings of small bowel
bstruction secondary to CD with a thickened small bowel wall
nd luminal narrowing that was evident at the transition zone in
2 of 14 examined patients [12].
Skip lesions or ﬁstula did not correlate with the histological
nﬂammatory activity score, since such ﬁndings reﬂect chronic
nﬂammation [13] and our patient cohort suffered from acute onset
nﬂammation. Additionally, mesenteric comb sign did not corre-
ate with histological inﬂammation, since it is also mainly found
n patients with chronic inﬂammation and only in few patients
ith acute inﬂammation. Comb sign is detected in up to 60% in
atients with inactive ulcerative colitis and up to 8% of patients with
rohn disease [14]. It may  also be seen in radiation enteritis, graftadiology Open 3 (2016) 74–78 77
versus host disease, and chronic ischemic bowel [14]. The localiza-
tion of CD did not correlate with inﬂammatory activity, which is
not surprising because CD can potentially occur anywhere in the GI
tract [13]. The predictive value of intestinal and extraintestinal CT
ﬁndings for inﬂammatory activity of CD may  be of relevance in sub-
jects whose pathology is located mainly in small bowel segments,
which are difﬁcult to access by endoscopy. In such cases, MDCT
may provide additional information about the status of inﬂamma-
tion and help to guide therapy. Moreover, the value of CT imaging
in CD lies not only in the estimation of inﬂammatory activity.
CT imaging offers the opportunity for detection of extraintestinal
manifestations of CD, such as spondylarthritis and sacroiliitis [15].
Also extraluminal abscess or the extent of a perforation cannot
be pre-estimated by endoscopy [8]. Moreover, ileoscopy offers a
very limited access to the small bowel due to its localization to the
terminal ileum [16].
MDCT provides a total overview of the small bowel. Moreover,
MDCT allows for the detection of metastases of malignant dis-
eases, which are hidden from endoscopy. This is of relevance since
patients with CD are at increased risk of small bowel adenocarci-
noma and lymphoma [17], which can result in liver metastasis and
adenopathy [17].
Therefore the predictive value of MDCT for inﬂammatory activ-
ity will not lead to a replacement of endoscopy, but MDCT is able
to provide complementary information with regard to small bowel
inﬂammation, extraintestinal manifestations and possible malig-
nant comorbidities.
There are several limitations of our study. First of all, the
radiation exposure of patients and the cancer risk due to the cumu-
lative radiation dose of CT in young patients are limiting factors.
Furthermore MDCT has a lower spatial resolution compared to
conventional enterography [8]. MRI  is an alternative noninvasive
imaging technique that can be used as a radiation-free alternative
for evaluation of patients with CD [18]. But in an emergency setting
CT is widely used in patients with abdominal pain [19]. In addition,
MDCT is less stressful for the patient in the acute period of CD com-
pared to MRI  since it is faster and less conﬁning [8]. Often a MDCT
scan is performed as the ﬁrst imaging method to rule out acute
abdominal pathology resulting in the diagnosis of CD [19]. CT is
also the fastest and most cost effective imaging method [20].
It is generally accepted that new CT techniques and advances
in postprocessing, e.g. iterative reconstructions, are an excellent
choice for radiation dose reduction without compromising image
quality [20]. O’Neill et al. used an effective dose of approximating 1
mSv  in patients with CD to conﬁrm the feasibility of sub-millisievert
abdominopelvic CT [21].
In conclusion, to prove the value of CT in the clinical assessment
of CD prospective studies are needed to determine whether infor-
mation gained from CT actually changes clinical decision-making
and outcomes.
5. Conclusion
Intestinal and extraintestinal CT-based biomarkers of bowel
inﬂammation including mesenteric adenopathy, wall thickness,
mesenteric fat stranding, and mesenteric abscess positively corre-
lated with the histological inﬂammatory activity score and can be
regarded as weak to moderate predictors of inﬂammatory activity.
Since inﬂammation of small bowel loops, extraintestinal manifes-
tations or complications as well as CD-related malignancies are
largely hidden from endoscopy; CT can provide complementary
information for therapy stratiﬁcation in patients with acute mani-
festations of CD.
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